InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Browse the detailed record of transactions filed by Tessier-Lavigne Marc, Director. Director active across 2 companies, notably Denali Therapeutics Inc.. In total, 20 disclosures have been published. Total volume traded: €4.3m. The latest transaction was filed on 2 June 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations20 total
05,986 shares0
Common Stock
SEC:0001714899-22-000096:0·
€254,4278,402 shares@ €30.28180.0099% mcap4.7% of flow
Common Stock
SEC:0001714899-22-000061:0·
€3m7,439 shares@ €344.96540.0035% mcap30.2% of flow
Common Stock
SEC:0001708138-22-000027:0·
€1m4,361 shares@ €341.0590.0020% mcap17.5% of flow
Common Stock
SEC:0001708138-22-000020:0·
0191 shares0
Common Stock
SEC:0001883850-22-000008·
0191 shares0
Common Stock
SEC:0001883850-22-000008:0·
0300,000 shares0
Common Stock
SEC:0001714899-21-000117·
0300,000 shares0
Common Stock
SEC:0001714899-21-000117:0·
€1m3,784 shares@ €327.3520.0017% mcap55.7% of flow
Common Stock
SEC:0001237899-21-000027·
€1m3,784 shares@ €327.3520.0017% mcap14.6% of flow
Common Stock
SEC:0001237899-21-000027:0·
€984,6784,250 shares@ €231.6890.0013% mcap44.3% of flow
Common Stock
SEC:0001708138-21-000080·
€984,6784,250 shares@ €231.6890.0013% mcap11.6% of flow
Common Stock
SEC:0001708138-21-000080:0·
€580,18339,303 shares@ €14.76180.023% mcap22.3% of flow
Common Stock
SEC:0001209191-21-038978·
€580,18339,303 shares@ €14.76180.023% mcap10.6% of flow
Common Stock
SEC:0001209191-21-038978:0·
02,074 shares0
Common Stock
SEC:0001209191-21-038393·
02,074 shares0
Common Stock
SEC:0001209191-21-038393:0·
€2m37,957 shares@ €49.1870.072% mcap71.7% of flow
Common Stock
SEC:0001209191-21-035548·
€2m37,957 shares@ €49.1870.072% mcap34.2% of flow
Common Stock
SEC:0001209191-21-035548:0·
€156,3613,139 shares@ €49.81230.0061% mcap6.0% of flow
Common Stock
SEC:0001209191-21-030304·
€156,3613,139 shares@ €49.81230.0061% mcap2.9% of flow
Common Stock
SEC:0001209191-21-030304:0·
20 of 20 declarations
About Tessier-Lavigne Marc
Marc Tessier-Lavigne is an executive at Denali Therapeutics Inc.
